2011

December 07, 2011
BTG plc: Voraxaze® (glucarpidase) licensed to Ohara Pharmaceuticals in Japan

London, UK, 07 December 2011 BTG plc (LSE: BGC), the specialist healthcare company, today announces that it has licensed the Japanese rights to glucarpidase to Ohara Pharmaceutical Co., Ltd....

November 17, 2011
BTG plc: Interim Results

London, UK, 17 November 2011 BTG plc (LSE: BGC), the specialist healthcare company, today announces its interim results for the six months ended 30 September 2011. Click here to down load the PDF

November 11, 2011
Garry Watts to succeed Dr John Brown as non-executive Chairman

London, UK, 11 November 2011 BTG plc (LSE: BGC), the specialist healthcare company, today announces that Garry Watts, FCA, MBE, is to succeed Dr John Brown, CBE, FRSE, as non-executive Chairman,...

November 01, 2011
BTG plc: Directorate Change

London, UK, 01 November 2011 BTG plc (LSE: BGC), the specialist healthcare company, announces that Rolf Soderstrom, Chief Financial Officer, is leaving the Company in order to take up the role of...

April 05, 2011
BTG plc: Close Period Update

London, UK, 05 April 2011 Revenues and cash in line with expectations Biocompatibles integration progressing well BTG plc (LSE: BGC), the specialist healthcare company, today provides the...

March 11, 2011
BTG plc: DEFEND-1 study of otelixizumab in type 1 diabetes did not meet primary endpoint

London, UK, 11 March 2011 BTG plc (LSE: BGC), the specialist healthcare company, notes today's announcement by Tolerx, Inc. and GlaxoSmithKline (GSK) that the Phase III DEFEND-1 study of...

January 27, 2011
BTG plc: Interim Management Statement

London, UK, 27 January 2011 BTG plc (LSE: BGC), the specialist healthcare company, today publishes its Interim Management Statement for the period from 1 October 2010 to 27 January 2011. Trading...

January 06, 2011
BTG to present at the J.P. Morgan Annual Healthcare Conference

London, UK, 06 January 2011 BTG plc (LSE: BGC), the specialty pharmaceuticals company, today announces that its CEO, Dr Louise Makin, will be presenting at J.P. Morgan's 29th Annual Healthcare...

Top